The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Human Studies of Angiogenic Gene Therapy
Open accessAbstract
Despite significant advances in medical, interventional, and surgical therapy for coronary and peripheral arterial disease, the burden of these illnesses remains high. To address this unmet need, the science of therapeutic angiogenesis has been evolving for almost two decades. Early preclinical studies and phase I clinical trials achieved promising results with growth factors administered as recombinant proteins or as single-agent gene therapies, and data accumulated through 10 years of clinical trials indicate that gene therapy has an acceptable safety profile. However, more rigorous phase II and phase III clinical trials have failed to unequivocally demonstrate that angiogenic agents are beneficial under the conditions and in the patients studied to date. Investigators have worked to understand the biology of the vascular system and to incorporate their findings into new treatments for patients with ischemic disease. Recent gene- and cell-therapy trials have demonstrated the bioactivity of several new agents and treatment strategies. Collectively, these observations have renewed interest in the mechanisms of angiogenesis and deepened our understanding of the complexity of vascular regeneration. Gene therapy that incorporates multiple growth factors, approaches that combine cell and gene therapy, and the administration of “master switch” agents that activate numerous downstream pathways are among the credible and plausible steps forward. In this review, we examine the clinical development of angiogenic gene therapy, summarize several of the lessons learned during the conduct of these trials, and suggest how this prior experience may guide the conduct of future preclinical investigations and clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 2,020
Eagle, K. A., Lim, M. J., Dabbous, O. H., Pieper, K. S., Goldberg, R. J., Van de Werf, F., Goodman, S. G., Granger, C. B., Steg, P. G., Gore, J. M., et al. (2004) · JAMA · doi:10.1001/jama.291.22.2727 · Cited by 1,588
Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., & Comoglio, P. M. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.629 · Cited by 1,337
Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,036
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B., Chew, A. J., J Tai, S., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,022
Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Self-citationHeparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
VEGF is required for growth and survival in neonatal mice
Gerber, H.-P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 915
Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes
Hochman, J. S., Tamis, J. E., Thompson, T. D., Weaver, W. D., White, H. D., Van de Werf, F., Aylward, P., Topol, E. J., & Califf, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410402 · Cited by 903
Nissen, N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L., & DiPietro, L. A. (1998) · Europe PMC (PubMed Central) · Cited by 842
Gospodarowicz, D. (1974) · Nature · doi:10.1038/249123a0 · Cited by 784
Age-Dependent Impairment of Angiogenesis
Rivard, A., Fabre, J.-E., Silver, M., Chen, D., Murohara, T., Kearney, M., Magner, M., Asahara, T., & Isner, J. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.111 · Cited by 771
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749
Parisi, A. F., Folland, E. D., & Hartigan, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260102 · Cited by 736
AAV vector integration sites in mouse hepatocellular carcinoma
Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science · doi:10.1126/science.1142658 · Cited by 662
Emerging Multipotent Aspects of Hepatocyte Growth Factor
Matsumoto, K., & Nakamura, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021283 · Cited by 660
Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
FERRARA, N. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70064-x · Cited by 623
Rajagopalan, S., Mohler, E. R., Lederman, R. J., Mendelsohn, F. O., Saucedo, J. F., Goldman, C. K., Blebea, J., Macko, J., Kessler, P. D., Rasmussen, H. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093398.16124.29 · Cited by 574
Reis, S. E., Holubkov, R., Smith, A. J. C., Kelsey, S. F., Sharaf, B. L., Reichek, N., Rogers, W. J., Merz, C. N. B., Sopko, G., & Pepine, C. J. (2001) · American Heart Journal · doi:10.1067/mhj.2001.114198 · Cited by 551
Ferrara, N. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37264 · Cited by 546
Hedman, M., Hartikainen, J., Syvänne, M., Stjernvall, J., Hedman, A., Kivelä, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070540.80780.92 · Cited by 537
Schumacher, B., Pecher, P., von Specht, B. U., & Stegmann, T. (1998) · Circulation · doi:10.1161/01.cir.97.7.645 · Cited by 531
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Grines, C. L., Watkins, M. W., Helmer, G., Penny, W., Brinker, J., Marmur, J. D., West, A., Rade, J. J., Marrott, P., Hammond, H. K., et al. (2002) · Circulation · doi:10.1161/hc1102.105595 · Cited by 519
Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth Factor
Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C., et al. (1992) · Science · doi:10.1126/science.1382313 · Cited by 517
Giordano, F. J., Ping, P., McKirnan, M. D., Nozaki, S., Demaria, A. N., Dillmann, W. H., Mathieu-Costello, O., & Hammond, H. K. (1996) · Nature Medicine · doi:10.1038/nm0596-534 · Cited by 486
Vascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Losordo, D. W., Vale, P. R., Hendel, R. C., Milliken, C. E., Fortuin, F. D., Cummings, N., Schatz, R. A., Asahara, T., Isner, J. M., & Kuntz, R. E. (2002) · Circulation · doi:10.1161/01.cir.0000015982.70785.b7 · Cited by 466
Self-citationEffective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Kastrup, J., Jørgensen, E., Rück, A., Tägil, K., Glogar, D., Ruzyllo, W., Bøtker, H. E., Dudek, D., Drvota, V., Hesse, B., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.068 · Cited by 459
Gene transfer as a tool to induce therapeutic vascular growth
Ylä-Herttuala, S., & Alitalo, K. (2003) · Nature Medicine · doi:10.1038/nm0603-694 · Cited by 404
Dor, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1939 · Cited by 390
Tsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S. T., Passeri, J., Horowitz, J. R., Symes, J. F., & Isner, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.12.3281 · Cited by 389
Mäkinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E., & Ylä-Herttuala, S. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0638 · Cited by 374
von Mering, G. O., Arant, C. B., Wessel, T. R., McGorray, S. P., Bairey Merz, C. N., Sharaf, B. L., Smith, K. M., Olson, M. B., Johnson, B. D., Sopko, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115525.92645.16 · Cited by 369
Nikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visoná, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Graham Wyatt, M., Dinesh Wijesinghe, L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.33 · Cited by 333
Baffour, R., Berman, J., Garb, J. L., Rhee, S. W., Kaufman, J., & Friedmann, P. (1992) · Journal of Vascular Surgery · doi:10.1016/0741-5214(92)90106-i · Cited by 324
Fibroblast growth factor regulation of neovascularization
Murakami, M., & Simons, M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f97d98 · Cited by 321
Kusumanto, Y. H., van Weel, V., Mulder, N. H., Smit, A. J., van den Dungen, J. J. A. M., Hooymans, J. M. M., Sluiter, W. J., Tio, R. A., Quax, P. H. A., Gans, R. O. B., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.683 · Cited by 318
Semenza, G. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21523 · Cited by 317
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., Varathalingam, A., Nunez-Alonso, G., Green, A.-M., Bazzani, R. P., Sumner-Jones, S. G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1399 · Cited by 310
Powell, R. J., Simons, M., Mendelsohn, F. O., Daniel, G., Henry, T. D., Koga, M., Morishita, R., & Annex, B. H. (2008) · Circulation · doi:10.1161/circulationaha.107.727347 · Cited by 303
Rivard, A., Berthou-Soulie, L., Principe, N., Kearney, M., Curry, C., Branellec, D., Semenza, G. L., & Isner, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001029200 · Cited by 303
Bosch-Marce, M., Okuyama, H., Wesley, J. B., Sarkar, K., Kimura, H., Liu, Y. V., Zhang, H., Strazza, M., Rey, S., Savino, L., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.153346 · Cited by 297
Grines, C. L., Watkins, M. W., Mahmarian, J. J., Iskandrian, A. E., Rade, J. J., Marrott, P., Pratt, C., & Kleiman, N. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00988-4 · Cited by 289
Stewart, D. J., Hilton, J. D., Arnold, J. M. O., Gregoire, J., Rivard, A., Archer, S. L., Charbonneau, F., Cohen, E., Curtis, M., Buller, C. E., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302802 · Cited by 281
Morishita, R., Nakamura, S., Hayashi, S.-I., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1379 · Cited by 267
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249
Comerota, A. J., Throm, R. C., Miller, K. A., Henry, T., Chronos, N., Laird, J., Sequeira, R., Kent, C. K., Bacchetta, M., Goldman, C., et al. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.123677 · Cited by 237
Morishita, R., Aoki, M., Hashiya, N., Makino, H., Yamasaki, K., Azuma, J., Sawa, Y., Matsuda, H., Kaneda, Y., & Ogihara, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000136394.08900.ed · Cited by 236
Effects of Ad5FGF-4 in Patients With Angina
Henry, T. D., Grines, C. L., Watkins, M. W., Dib, N., Barbeau, G., Moreadith, R., Andrasfay, T., & Engler, R. L. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.010 · Cited by 224
Recombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 215
Laitinen, M., Hartikainen, J., Hiltunen, M. O., Eranen, J., Kiviniemi, M., Narvanen, O., Makinen, K., Manninen, H., Syvanne, M., Martin, J. F., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050016003 · Cited by 212
Biological activities of fibroblast growth factor-2 in the adult myocardium
Detillieux, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00708-3 · Cited by 201
Laitinen, M., Mäkinen, K., Manninen, H., Matsi, P., Kossila, M., Agrawal, R. S., Pakkanen, T., Luoma, J. S., Viita, H., Hartikainen, J., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.10-1481 · Cited by 198
Rissanen, T. T., Vajanto, I., Hiltunen, M. O., Rutanen, J., Kettunen, M. I., Niemi, M., Leppänen, P., Turunen, M. P., Markkanen, J. E., Arve, K., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62566-7 · Cited by 193
Rajagopalan, S., Olin, J., Deitcher, S., Pieczek, A., Laird, J., Grossman, P. M., Goldman, C. K., McEllin, K., Kelly, R., & Chronos, N. (2007) · Circulation · doi:10.1161/circulationaha.106.607994 · Cited by 187
Leong-Poi, H., Kuliszewski, M. A., Lekas, M., Sibbald, M., Teichert-Kuliszewska, K., Klibanov, A. L., Stewart, D. J., & Lindner, J. R. (2007) · Circulation Research · doi:10.1161/circresaha.107.148676 · Cited by 165
Zia, M. I., Siu, L. L., Pond, G. R., & Chen, E. X. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.679 · Cited by 157
Assessment of Risks Associated With Cardiovascular Gene Therapy in Human Subjects
Isner, J. M., Vale, P. R., Symes, J. F., & Losordo, D. W. (2001) · Circulation Research · doi:10.1161/hh1701.096259 · Cited by 149
Self-citationRipa, R. S., Wang, Y., Jørgensen, E., Johnsen, H. E., Hesse, B., & Kastrup, J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl117 · Cited by 144
Gene and cell therapy : therapeutic mechanisms and strategies
Templeton, N. S. (2004) · Cited by 142
Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1
Zhong, J., Eliceiri, B. P., Stupack, D. G., Penta, K., Sakamoto, G. T., Quertermous, T., Coleman, M., Boudreau, N. J., & Varner, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17034 · Cited by 135
Hutter, R., Carrick, F. E., Valdiviezo, C., Wolinsky, C., Rudge, J. S., Wiegand, S. J., Fuster, V., Badimón, J. J., & Sauter, B. V. (2004) · Circulation · doi:10.1161/01.cir.0000145120.37891.8a · Cited by 123
Therapeutic Angiogenesis in Ischemic Limbs
Folkman, J. (1998) · Circulation · doi:10.1161/01.cir.97.12.1108 · Cited by 115
Gyöngyösi, M., Khorsand, A., Zamini, S., Sperker, W., Strehblow, C., Kastrup, J., Jorgensen, E., Hesse, B., Tägil, K., Bøtker, H. E., et al. (2005) · Circulation · doi:10.1161/01.circulationaha.105.525782 · Cited by 114
Gene therapy: targeting the myocardium
Lyon, A. R., Sato, M., Hajjar, R. J., Samulski, R. J., & Harding, S. E. (2007) · Heart · doi:10.1136/hrt.2007.116483 · Cited by 112
Boodhwani, M., Sodha, N. R., Mieno, S., Xu, S., Feng, J., Ramlawi, B., Clements, R., & Sellke, F. W. (2007) · Circulation · doi:10.1161/circulationaha.106.680157 · Cited by 97
Wright, M. J., Wightman, L., Lilley, C. E., de Alwis, M., Hart, S. L., Miller, A. D., Coffin, R. S., Thrasher, A. J., Latchman, D. S., & Marber, M. S. (2001) · Basic Research in Cardiology · doi:10.1007/s003950170053 · Cited by 94
Reyes‐Sandoval, A., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.008 · Cited by 94
Grossman, P. M., Mendelsohn, F. O., Henry, T. D., Hermiller, J. B., Litt, M. R., Saucedo, J. F., Weiss, R., Kandzari, D. E., Kleiman, N. S., Anderson, R. D., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.038 · Cited by 89
Quantification of Absolute Myocardial Blood Flow by Magnetic Resonance Perfusion Imaging
Lee, D. C., & Johnson, N. P. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.04.003 · Cited by 84
Non-Integrating Lentiviral Vectors
Sarkis, C., Philippe, S., Mallet, J. J., & Serguera, C. (2008) · Current Gene Therapy · doi:10.2174/156652308786848012 · Cited by 83
In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo
Wright, M. J., Wightman, L., Latchman, D. S., & Marber, M. S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301614 · Cited by 74
Age and outcome after acute coronary syndromes without persistent ST-segment elevation
Hasdai, D., Holmes, D. R., Criger, D. A., Topol, E. J., Califf, R. M., & Harrington, R. A. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90018-8 · Cited by 71
Azuma, J., Taniyama, Y., Takeya, Y., Iekushi, K., Aoki, M., Dosaka, N., Matsumoto, K., Nakamura, T., Ogihara, T., & Morishita, R. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302740 · Cited by 69
Johnson, N. P., & Gould, K. L. (2005) · PubMed · Cited by 63
Rana, J. S., Mannam, A. P., Donnell‐Fink, L. A., Gervino, E. V., Sellke, F. W., & Laham, R. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.02.013 · Cited by 62
Impaired Coronary Vascular Reactivity and Functional Capacity in Women
Handberg, E. M., Johnson, B. D., Arant, C. B., Wessel, T. R., Kerensky, R. A., Mering, G. V., Olson, M. B., Reís, S. E., Shaw, L. J., Merz, C. N. B., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.023 · Cited by 47
Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres
Hoshino, K., Kimura, T., Grand, A. M. D., Yoneyama, R., Kawase, Y., Houser, S. L., Ly, H. Q., Kushibiki, T., Furukawa, Y., Ono, K., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302793 · Cited by 40
Krum, H., & Tonkin, A. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00018-6 · Cited by 30
New Vectors and Strategies for Cardiovascular Gene Therapy
Jaźwa, A., Józkowicz, A., & Dulak, J. (2007) · Current Gene Therapy · doi:10.2174/156652307779940243 · Cited by 23
Lenihan, D. J., Osman, A., Sriram, V., Aitsebaomo, J., & Patterson, C. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00429.2002 · Cited by 13
Cited by
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
Losordo, D. W., Henry, T. D., Davidson, C., Sup Lee, J., Costa, M. A., Bass, T., Mendelsohn, F., Fortuin, F. D., Pepine, C. J., Traverse, J. H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.245993 · Cited by 482
Self-citationVascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
Belch, J., Hiatt, W. R., Baumgartner, I., Driver, I. V., Nikol, S., Norgren, L., & Van Belle, E. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60394-2 · Cited by 341
Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair
Webber, M. J., Tongers, J., Newcomb, C. J., Marquardt, K.-T., Bauersachs, J., Losordo, D. W., & Stupp, S. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016546108 · Cited by 324
Self-citation
Metadata
- Authors
- Gupta, R., Tongers, J., & Losordo, D. W.
- Venue
- Circulation Research
- Published
- 2009-10-09
- Volume
- 105
- Issue
- 8
- Pages
- 724-736
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2141894953
- Cited by
- 276
- References
- 94
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.